Amrize Ltd (AMRZ) Key Metrics
AMRZ valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $20.68B
- Enterprise value
- $27.37B
- P/E (TTM)
- 17.3
- Forward P/E
- 13.4
- PEG ratio
- 1.04
- Price / sales
- 1.7
- Price / book
- 1.6
- EV / EBITDA
- 9.6
- Dividend yield
- 1.16% $0.44 a year
- Beta
- —
AMRZ key metrics, 2021–2025
Fiscal year ended December 31, 2025 · U.S. dollarsAMRZ returns How much profit the business earns on the capital it uses.
AMRZ per-share figures Results divided by the shares outstanding at year-end.
AMRZ financial health Debt, liquidity and how easily interest is covered.
AMRZ efficiency & capital use Working capital cycle and where the cash goes.
AMRZ valuation history
AMRZ returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
AMRZ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
AMRZ price vs earnings per share
AMRZ key metrics
2021–2025| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $29.94B | — | — | — | — |
| Enterprise value | $33.92B | — | — | — | — |
| P/E ratio | 25.3 | — | — | — | — |
| Price / sales | 2.5 | — | — | — | — |
| Price / book | 2.3 | — | — | — | — |
| Price / free cash flow | 21.1 | — | — | — | — |
| Price / operating cash flow | 13.6 | — | — | — | — |
| EV / sales | 2.9 | — | — | — | — |
| EV / EBITDA | 12.0 | — | — | — | — |
| EV / free cash flow | 23.9 | — | — | — | — |
| Earnings yield | 4.0% | — | — | — | — |
| Free cash flow yield | 4.7% | — | — | — | — |
| Share price at fiscal year-end | $54.08 | — | — | — | — |
| Per share | |||||
| Revenue per share | $21.34 | $21.15 | $21.13 | $19.41 | $14.71 |
| Earnings per share | $2.14 | $2.30 | $1.73 | $2.00 | $1.52 |
| Operating cash flow per share | $3.99 | $4.12 | $3.68 | $3.60 | $2.70 |
| Free cash flow per share | $2.57 | $2.96 | $2.54 | $2.71 | $1.99 |
| Cash per share | $3.47 | $3.30 | $2.00 | $0.64 | — |
| Book value per share | $23.94 | $24.05 | $16.65 | $14.85 | — |
| Tangible book value per share | $4.53 | $4.62 | −$2.99 | −$2.44 | — |
| Capex per share | $1.42 | $1.16 | $1.14 | $0.88 | $0.71 |
| Debt per share | $10.67 | $10.46 | $17.23 | $15.67 | — |
| Shares outstanding | 553.6M | 553.3M | 552.7M | 552.7M | 552.7M |
| Change in shares outstanding | +0.1% | +0.1% | 0.0% | 0.0% | — |
| Returns & profitability | |||||
| Return on equity (ROE) | 8.9% | 11.3% | 11.0% | 13.5% | — |
| Return on invested capital (ROIC) | 8.7% | 9.5% | 8.0% | 7.7% | — |
| Return on assets (ROA) | 5.0% | 5.5% | 4.4% | 5.4% | — |
| Return on tangible assets | 8.8% | 10.0% | 7.8% | 10.0% | — |
| Free cash flow margin | 12.0% | 14.0% | 12.0% | 14.0% | 13.5% |
| Income quality (OCF / net income) | 1.86 | 1.79 | 2.13 | 1.79 | 1.77 |
| Financial health | |||||
| Total debt | $5.91B | $5.79B | $9.52B | $8.66B | — |
| Cash & short-term investments | $1.92B | $1.82B | $1.11B | $351.0M | — |
| Net debt | $3.98B | $3.96B | $8.42B | $8.31B | — |
| Debt / equity | 0.45 | 0.43 | 1.03 | 1.05 | — |
| Debt / assets | 0.24 | 0.25 | 0.41 | 0.42 | — |
| Net debt / EBITDA | 1.41 | 1.31 | 3.11 | 3.33 | — |
| Current ratio | 1.64 | 1.85 | 1.61 | 1.40 | — |
| Quick ratio | 1.10 | 1.25 | 1.08 | 0.86 | — |
| Interest coverage | 4.6 | 7.0 | 3.4 | 6.9 | 7.2 |
| Working capital | $1.82B | $2.06B | $1.50B | $906.0M | — |
| Invested capital | $17.24B | $17.27B | $17.62B | $16.52B | — |
| Tangible asset value | $2.51B | $2.56B | −$1.65B | −$1.35B | — |
| Net current asset value | −$6.31B | −$5.72B | −$9.90B | −$9.30B | — |
| Graham number | $33.96 | $35.30 | $25.46 | $25.88 | — |
| Graham net-net per share | −$13.47 | −$12.40 | −$19.97 | −$18.88 | — |
| Capital allocation | |||||
| Capex / revenue | 6.7% | 5.5% | 5.4% | 4.5% | 4.8% |
| Capex / operating cash flow | 35.7% | 28.1% | 30.9% | 24.5% | 26.4% |
| Capex / depreciation | 0.86 | 0.73 | 0.74 | 0.62 | 0.55 |
| Stock-based compensation / revenue | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% |
| SG&A / revenue | 9.5% | 7.9% | 7.7% | 7.0% | 6.8% |
| Efficiency | |||||
| Days sales outstanding | 33.8 | 38.5 | 43.9 | 48.0 | — |
| Days of inventory on hand | 62.4 | 58.3 | 51.9 | 54.3 | — |
| Days payables outstanding | 60.5 | 55.4 | 49.0 | 50.6 | — |
| Cash conversion cycle (days) | 35.7 | 41.4 | 46.8 | 51.7 | — |
| Receivables turnover | 10.79 | 9.49 | 8.32 | 7.61 | — |
| Payables turnover | 6.03 | 6.59 | 7.45 | 7.22 | — |
| Inventory turnover | 5.85 | 6.26 | 7.03 | 6.72 | — |
| Asset turnover | 0.49 | 0.50 | 0.53 | 0.52 | — |
| Average receivables | $1.09B | $1.23B | $1.40B | $1.41B | — |
| Average payables | $1.46B | $1.31B | $1.20B | $1.14B | — |
| Average inventory | $1.50B | $1.38B | $1.27B | $1.23B | — |
| Intangibles / total assets | 44.3% | 45.7% | 47.1% | 46.2% | — |
Computed from AMRZ's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
AMRZ valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Amrize traded at 25.3 times earnings. Based on the latest twelve months, the trailing P/E is 17.3 and the forward P/E is 13.4. Amrize earned a return on equity of 8.9% and a return on invested capital of 8.7% in fiscal 2025. It ended the year with $5.9 billion of debt and $1.9 billion in cash and short-term investments, net debt of $4.0 billion.
See the AMRZ income statement, the AMRZ chart for price history, or the AMRZ stock overview for the latest quote and news.
AMRZ key metrics FAQ
What is Amrize's P/E ratio?
Amrize's trailing P/E ratio is 17.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 13.4. At the end of fiscal 2025 it was 25.3.
What is Amrize's EV/EBITDA?
Amrize's enterprise value was 12.0 times EBITDA at the end of fiscal 2025 (enterprise value $33.9 billion, EBITDA $2.8 billion); the current EV/EBITDA is 9.6.
What is Amrize's return on equity?
Amrize's return on equity (ROE) was 8.9% in fiscal 2025: net income of $1.2 billion on average shareholders' equity of $13.3 billion.
What is Amrize's ROIC?
Amrize's return on invested capital was 8.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Amrize have?
Amrize had total debt of $5.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.45 and $4.0 billion of net debt (1.41 times EBITDA).
What is Amrize's free cash flow yield?
Amrize generated $1.4 billion of free cash flow in fiscal 2025, a free cash flow yield of 4.7% on its market value at year-end ($29.9 billion).
What is Amrize's current ratio?
Amrize's current ratio was 1.64 at the end of fiscal 2025: current assets were 1.64 times current liabilities.